AMGN
NASD Amgen, Inc.$418.13 ↑ +0.00 (+0.00%) Trading Up from the previous close of $418.13, $0.89 below the day’s high of $419.02
- YTD change
- +27.75%
- vs 20-day SMA
- +3.27%
- vs 200-day SMA
- +15.47%
Price ranges
Price & Performance
+69.13 (+19.81%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 6.5% away from all-time highs of $447.03
- AMGN is up 28% since the beginning of the year
- AMGN is up 53% over the past 12 months
- AMGN is down 4% over the past 1 month
- 2% of all AMGN investors are betting against AMGN
AMGN reads very good: price sits above both the 20- and 200-day averages, the 12-month move is +52.6%.
- Previous minute
- +$0.01
- Last hour
- +$0.52
- Last 5 days
- +8.42%
- vs 8-day SMA
- +5.46%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.
Competitor comparison
No peer group available for this symbol.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.